SkinHealth Systems Inc.
NASDAQ Capital MarketTotal Valuation
SkinHealth Systems Inc. carries a market capitalization of 110.56M, placing it among publicly traded companies globally. Its enterprise value stands at 275.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 110.56M |
| Enterprise Value | 275.84M |
Share Statistics
SkinHealth Systems Inc. currently has 129.14M shares outstanding.
| Shares Outstanding | 129.14M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.38, and the price-to-book ratio stands at -0.22.
| PE Ratio | N/A |
| PS Ratio | 0.38 |
| PB Ratio | -0.22 |
| P/TBV Ratio | -1.09 |
| P/FCF Ratio | 3.38 |
| P/OCF Ratio | 3.91 |
Enterprise Valuation
On an enterprise value basis, SkinHealth Systems Inc. trades at an EV/EBITDA multiple of 19.79 and an EV/FCF ratio of 3.72.
| EV / Sales | 0.93 |
| EV / EBITDA | 19.79 |
| EV / EBIT | N/A |
| EV / FCF | 3.72 |
Financial Position
SkinHealth Systems Inc. maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 664.61, indicating elevated leverage, while an interest coverage ratio of 0.60 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.79 |
| Quick Ratio | 1.45 |
| Debt / Equity | 664.61 |
| Debt / EBITDA | 26.34 |
| Interest Coverage | 0.60 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.83 |
Taxes
| Income Tax | 2.51M |
| Effective Tax Rate | N/A |
Stock Price Statistics
SkinHealth Systems Inc.'s stock has declined approximately -48.60843% over the past 52 weeks. The 50-day moving average sits at 0.73, while the 200-day moving average is 1.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -48.60843% |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 1.14 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, SkinHealth Systems Inc. generated 296.12M in revenue and converted that into -6.05M in net income, yielding earnings per share of -0.05. EBITDA reached 13.94M, while operating income came in at -10.58M.
| Revenue | 296.12M |
| Gross Profit | 192.22M |
| Operating Income | -10.58M |
| Pretax Income | -3.55M |
| Net Income | -6.05M |
| EBITDA | 13.94M |
| EBIT | -10.58M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
SkinHealth Systems Inc. holds 204.36M in cash and equivalents against 367.13M in total debt, resulting in a net debt position of 139.86M. Total book value stands at -524.10M, with working capital of 122.49M providing operational flexibility.
| Cash & Cash Equivalents | 204.36M |
| Total Debt | 367.13M |
| Net Debt | 139.86M |
| Equity (Book Value) | -524.10M |
| Book Value Per Share | -4.13 |
| Working Capital | 122.49M |
Cash Flow
SkinHealth Systems Inc. produced 28.94M in operating cash flow over the past twelve months. After subtracting -5.67M in capital expenditures, free cash flow totaled 23.27M - equivalent to 0.18 per share.
| Operating Cash Flow | 28.94M |
| Capital Expenditures | -5.67M |
| Free Cash Flow | 23.27M |
| FCF Per Share | 0.18 |
Margins
SkinHealth Systems Inc. operates with a gross margin of 64.91, reflecting its pricing power and cost economics. The operating margin of -3.57 and net profit margin of -2.04 provide insight into operational efficiency.
| Gross Margin | 64.91 |
| Operating Margin | -3.57 |
| Pretax Margin | -1.20 |
| Profit Margin | -2.04 |
| EBITDA Margin | 4.71 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 172.97 |
| FCF Yield | 29.56 |
Scores
SkinHealth Systems Inc. posts an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.87 |